Zong Li-li, Ma Li, Wang Xiao-ning, Zhang Jin-hua, He Yuan-li
Department of Obstetrics and Gynecology, Zhujiang Hospital, First Military Medical University, Guangzhou 510282, China.
Zhonghua Fu Chan Ke Za Zhi. 2004 Jan;39(1):24-6.
To study the function of heparanase gene in the pathogenesis of endometriosis.
In situ hybridization method was used to examine the heparanase mRNA expression in the eutopic and ectopic endometrium of patients with endometriosis (EM group, 23) and the eutopic endometrium of women without endometriosis (control group, 25).
(1) In EM group: The frequency of heparanase gene expression in eutopic was similar to that in ectopic endometrium. However the number of positive cells and the intensity of heparanase gene expression in ectopic endometrium was more than that in eutopic endometrium. The frequency of heparanase gene expression in proliferative phase was 83.3% (10/12), while in secretory phase it was 72.7% (8/11), the difference is not significant; (2) In control group: The frequency of heparanase gene expression in proliferative phase was 41.7% (5/12), while in secretory phase it was 7.7% (1/13), the difference is significant; (3) The frequency of heparanase gene expression in endometrium of patients with endometriosis and women without endometriosis were 78.3% (18/23) and 24.0% (6/25) respectively, the difference is significant.
Heparanase gene may play some roles in the pathogenesis of endometriosis, and it may participate the regulation of menstrual cycle, and that it may participate the regulation of menstrual cycle. It may be an important target of the trentment for endometriosis.
研究乙酰肝素酶基因在子宫内膜异位症发病机制中的作用。
采用原位杂交法检测子宫内膜异位症患者(子宫内膜异位症组,23例)在位及异位内膜组织中乙酰肝素酶mRNA的表达情况,并以非子宫内膜异位症患者的在位内膜组织作为对照(对照组,25例)。
(1)子宫内膜异位症组:在位内膜组织中乙酰肝素酶基因表达阳性率与异位内膜组织相近,但异位内膜组织中乙酰肝素酶基因表达阳性细胞数及表达强度均高于在位内膜组织。增殖期乙酰肝素酶基因表达阳性率为83.3%(10/12),分泌期为72.7%(8/11),差异无统计学意义;(2)对照组:增殖期乙酰肝素酶基因表达阳性率为41.7%(5/12),分泌期为7.7%(1/13),差异有统计学意义;(3)子宫内膜异位症患者内膜组织中乙酰肝素酶基因表达阳性率为78.3%(18/23),非子宫内膜异位症患者内膜组织中乙酰肝素酶基因表达阳性率为24.0%(6/25),差异有统计学意义。
乙酰肝素酶基因可能在子宫内膜异位症发病机制中起一定作用,可能参与月经周期的调节,有望成为子宫内膜异位症治疗的重要靶点。